well Joko de Joane actually neither are in business yet. Why hasn't GERN booked their upfront payment yet from J&J? Why does Scarlet keep consistent on his stance that GERON will not be pursuing any special designation for IMET? and why do you unnecessary pump irrelevant lame info such as 60 minutes specials on a mouse from Capernaum? Where is Dr. T in all this? He hasn't to anyone's knowledge even mentioned IMET since ASH 2014. What happened? What happened to Irish future trader's updates? Why did we rotate the entire float with high vol 2 weeks back following the last CC on no new news?
If Janssen agrees to move ahead with the trials then this will fly. If not we die. This past week we witnessed two stocks I'm very familiar with MEIP & OHRP getting a 70% haircut from failed test results. GERN would make it a bald beaver hat trick fur me. Currently long on GERN but shaken in my wet webbed feet.
Alex 44 without doing any research on a stock being up 300% in your portfolio is that all subject to short term capital gains tax? Are you still holding?
did you just make_up_name_talk_to_myself Joko? You really did mean the third rail.
it's barebutt Bob to u joker
both MEIP and OHRP had a larger pipelines albeit limited, not only one drug like GERON's IMET. MEIP's combo drug produced similar CR's in late stage AML as did GERN's in MF trial studies. Meip's earlier stage AML therapy did not support these MDS data results and hence the recent drop in their SP. Would IMET work any better in earlier stage MDS? We still await our AML data.
U are basing everything here on GERN's phase 2 results, that are demonstrating durability based heavily on one poster's 'candid' experience via a third party. If it turn's out to be all misinformation, who you gonna call, ghost busters?
Furthermore IMET needs to expand it's target market beyond MF to remain a competitive drug. That is still a major hurdle to over come. Until we see expanded planned trial data, it's still a 50/50 bet at best.
Surprised at MEIP's stark 60% drop, no so much on OHRP's but being cautious now on GERN as there are too many things that do not sit well and can still go wrong. BM's "veil of silence" is disconcerting as we are seldom kept abreast of developments until after the fact.
You'd be a fool not to weigh in the potential down side here. Janssen could easily pulling out or be just awaiting for an opportunity to get a fire sale buy out on a potentially promising drug pipeline by deliberately holding off on going fwd. 3 of the last big company buy outs I experienced over the past 2 years was stacked in favor of the BOD and short changed the shareholders involved. We turned over the market cap at least once during those high vol days 2 weeks ago. Who. why and what was the cause still has to be determined. If you have the unequivocal true answer to this it's all still just conjecture.
all we need is an ACAD like announcement. Wouldn't be the first time GERN (now under J&J) issued a press release announcing a change in the timing of its planned NDA submission to the FDA. Dr T has mysteriously disappeared since I met ASH 2014
you lie like a rug Joko creating false expectations/ I'm just laid up on the Gerney all year waiting to break even here. The more you pump the more I'll post.
what's the point...he seldom answers anyways. Even investor reps don't bother asking anymore. Did you notice the number or rather lack of questions following the CEO biotech conference in NY earlier this year?
a good beaver never reveals his lodge log entry positions but I started buying puts 2wks ago in both stocks following volume.. Was long in MEIP after selling off most gains & had only a fraction left of what I had earlier. Couldn't get much on their combo trial data comparatives so I wasn't sure of holding through the event. Usually if there's a 2-3 wk delay it's a warning. Companies try to get 'good' news out as fast as possible. Buying puts seemed like a good counter play if the data wasn't good and the activity increase on the put side prior to supported that premise. In OHRP was from being aware of what they do...pump & dump it & repeat. I actually got burnt holding once in it.
well MEIP ended up being a great trading stock especially if you played the put options on their last binary. I Made some on the rally from Jan , and sold most before the trial results ...almost 3 weeks overdue. Couldn't figure out the combo trial data and it reminded of another pharma scam OHRP. I played it last year and had bought $5 puts on their recent binary failure.(1,300% return) like in MEIP(350% return which more than compensated for the losses in what was left of my long position down 65%). OHIP went from $1-$20 in two years and then crashed to $4 and now a recent run up to $10. crashing back down to $2.74. Both will experience a dead cat bounce IMO but I'm not recommending to play them unless you can afford to lose and have studied their option plays.
After saying all this what is the worst case scenario wrt GERN if Janssen just is't that into GERN. Does Scarlet have to refund options exercised? Does Joko have to find a new handle for his pump? Does beaver finally drown in his lodge? What happens to all the cancer patents still on IMET? How many are still being treated in the on going trials?
"Indiana wants me but I can't go back now
Indiana wants me but I can't go back now",
, at least not now that I've got my significant other
to talk too.
Utah just approved an execution firing squad. Next they'll be stoning people to death in Boulder Colorado.
Nice holidays in Maine...don't blame you for leaving Arkansas...rated as worse state to retire in.
Oh and thanks for your sage advice on GERN. Wouldn't want to sell out too early as you advised in AST.
Any other words of wisdom?
Lately they've been dropping the price on much smaller dumps , mainly in the afternoon when buying activity subsides.
I agree logic would have it but o Wall Street it's not hard to do with HFT platforms bidding up small increments of blocks sparking higher d3emand and then selling off into that demand dropping price and then repeating this process. I forget which day I saw 158.3K blocks ...at least 20 of them pushed through the day. If those were buys the fundamental support would have held up. We soon dropped back down. I haven't seen any current filings on sells other than those of the compensation committee chair for options. Blackrock, State & FMR increased their position a month ago.
I believe he referred to them as 'super investors'
"'Weak on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news, analyst downgrades, insider selling, selling from 'superinvestors,' or that hedge funds and traders are piling out of a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize (or avoid losses by trimming weak positions). In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success."
I never put much validity in these articles by the street but I still can't get past that volume conundrum we saw. Maybe indifferent drummer can comment on that con-un-drum.